My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Schrodinger, Inc. - Common Stock (NQ:SDGR)

13.49 +0.55 (+4.25%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

From Schrödinger

Via Business Wire

Schrödinger to Participate in Upcoming Investor Conferences

November 06, 2023

From Schrödinger

Via Business Wire

Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

November 02, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Third Quarter 2023 Financial Results

November 01, 2023

From Schrödinger

Via Business Wire

Schrödinger to Host Pipeline Day on December 14, 2023

October 30, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 23, 2023

From Schrödinger

Via Business Wire

Schrödinger to Announce Third Quarter 2023 Financial Results on November 1

October 18, 2023

From Schrödinger

Via Business Wire

Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education

September 28, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

September 18, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

September 05, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

August 11, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger Reports Second Quarter 2023 Financial Results

August 02, 2023

From Schrödinger, Inc.

Via Business Wire

Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

August 01, 2023

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

Via MarketBeat

Topics Artificial Intelligence

Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential

July 28, 2023

A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.

Via MarketBeat

Topics Artificial Intelligence

Exscientia is the Sniper of the AI Drug Discovery Industry

July 27, 2023

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

Via MarketBeat

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

July 20, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Announce Second Quarter 2023 Financial Results on August 2

July 19, 2023

From Schrödinger, Inc.

Via Business Wire

Nvidia Invested $50 million into This AI Drug Discovery Biotech

July 17, 2023

Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from

Via MarketBeat

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 22, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference

June 01, 2023

From Schrödinger

Via Business Wire

Schrödinger to Present at Jefferies Global Biopharma Conference

May 26, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 25, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger Reports Strong First Quarter 2023 Financial Results

May 04, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger Publishes Inaugural Corporate Sustainability Report

April 27, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Announce First Quarter 2023 Financial Results on May 4

April 20, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 19, 2023

From Schrödinger, Inc.

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

March 22, 2023

From Schrödinger, Inc.

Via Business Wire

MarketBeat Week in Review – 3/6 - 3/10

March 11, 2023

Stocks are down sharply to end the week, and the MarketBeat staff continues to show investors why dividend stocks need to be part of your playbook

Via MarketBeat

Topics Artificial Intelligence Economy

Schrodinger is an AI-Powered Drug Discovery Developer to Watch

March 08, 2023

Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117

Via MarketBeat

Topics Artificial Intelligence

Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results

February 28, 2023

From Schrödinger, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.